Skip to main navigation
Skip to search
Skip to main content
Tel Aviv University Home
Update Request & User Guide (TAU staff only)
Home
Experts
Research units
Research output
Prizes
Activities
Press/Media
Search by expertise, name or affiliation
Is immunosuppressive treatment an option for myocarditis?
M. Jonas,
H. Hod
*
*
Corresponding author for this work
Sheba Medical Center at Tel Hashomer
Research output
:
Contribution to journal
›
Short survey
›
peer-review
9
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Is immunosuppressive treatment an option for myocarditis?'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Myocarditis
100%
Immunosuppressive Therapy
100%
Heart Failure
33%
Polymerase Chain Reaction
16%
Etiology
16%
Inflammatory Diseases
16%
Immunosuppressive Drugs
16%
Disease Course
16%
Epidemiology
16%
In Situ Hybridization
16%
Murine Model
16%
Immunosuppression
16%
Cardiac Disease
16%
Natural Course
16%
Identification Method
16%
Pregenomic RNA (pgRNA)
16%
RNA Detection
16%
Proviral DNA
16%
Routine Treatment
16%
Treatment Trials
16%
Immunohistochemical Method
16%
Viral Myocarditis
16%
Immunohistochemical Markers
16%
Medical Regimen
16%
Acute Myocarditis
16%
Chronic Myocarditis
16%
Dallas Criteria
16%
European Studies
16%
Myocardial Biopsy
16%
DNA Identification
16%
Medicine and Dentistry
Myocarditis
100%
Immunosuppressive Treatment
100%
Heart Failure
28%
Disease
14%
Symptom
14%
Polymerase Chain Reaction
14%
Virus RNA
14%
Heart Disease
14%
Heart Muscle Biopsy
14%
Cohort Effect
14%
Heart Death
14%
Inflammatory Disorder
14%
in Situ Hybridization
14%
Immunosuppressive Drug
14%
Virus DNA
14%
Virus Myocarditis
14%
Pharmacology, Toxicology and Pharmaceutical Science
Myocarditis
100%
Immunosuppressive Agent
100%
Heart Failure
28%
Disease
14%
Inflammatory Disease
14%
Symptom
14%
Heart Disease
14%
Heart Death
14%
Virus RNA
14%
Virus DNA
14%
Virus Myocarditis
14%